Mogy Joel R Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.8M Sell
30,730
-200
-0.6% -$46.6K 0.45% 32
2026
Q1
$7.56M Sell
30,930
-600
-2% -$140K 0.47% 33
2025
Q4
$6.53M Hold
31,530
0.35% 36
2025
Q3
$5.85M Hold
31,530
0.32% 37
2025
Q2
$4.82M Sell
31,530
-150
-0.5% -$23.1K 0.28% 39
2025
Q1
$5.25M Sell
31,680
-6,640
-17% -$1.04M 0.34% 40
2024
Q4
$5.54M Sell
38,320
-345
-0.9% -$53.5K 0.33% 40
2024
Q3
$6.27M Sell
38,665
-3,529
-8% -$562K 0.38% 37
2024
Q2
$6.17M Sell
42,194
-276
-0.6% -$41K 0.39% 36
2024
Q1
$6.72M Sell
42,470
-19,866
-32% -$3.16M 0.46% 38
2023
Q4
$9.77M Sell
62,336
-8,419
-12% -$1.29M 0.74% 33
2023
Q3
$11M Sell
70,755
-88,682
-56% -$14.6M 0.93% 28
2023
Q2
$26.4M Sell
159,437
-1,361
-0.8% -$220K 2.1% 20
2023
Q1
$24.9M Sell
160,798
-1,345
-0.8% -$217K 2.21% 19
2022
Q4
$28.6M Sell
162,143
-3,274
-2% -$565K 2.86% 10
2022
Q3
$27M Buy
165,417
+360
+0.2% +$60.9K 2.83% 13
2022
Q2
$29.3M Sell
165,057
-136
-0.1% -$24.2K 2.89% 11
2022
Q1
$29.3M Sell
165,193
-5,434
-3% -$925K 2.32% 16
2021
Q4
$29.2M Sell
170,627
-100
-0.1% -$16.4K 2.09% 17
2021
Q3
$27.6M Sell
170,727
-50
-0% -$8.53K 2.26% 17
2021
Q2
$28.1M Sell
170,777
-1,403
-0.8% -$232K 2.38% 16
2021
Q1
$28.3M Buy
172,180
+131
+0.1% +$21.2K 2.72% 13
2020
Q4
$27.1M Sell
172,049
-1,025
-0.6% -$151K 2.67% 12
2020
Q3
$25.8M Sell
173,074
-1,785
-1% -$264K 2.77% 11
2020
Q2
$24.6M Sell
174,859
-1,627
-0.9% -$237K 2.94% 11
2020
Q1
$23.1M Sell
176,486
-1,655
-0.9% -$235K 3.29% 10
2019
Q4
$26M Sell
178,141
-1,958
-1% -$266K 3.11% 10
2019
Q3
$23.3M Sell
180,099
-1,497
-0.8% -$197K 2.95% 12
2019
Q2
$25.3M Buy
181,596
+626
+0.3% +$86.7K 3.29% 10
2019
Q1
$25.3M Sell
180,970
-612
-0.3% -$82K 3.42% 10
2018
Q4
$23.4M Buy
181,582
+545
+0.3% +$76K 3.64% 7
2018
Q3
$25M Buy
181,037
+428
+0.2% +$56.9K 3.36% 9
2018
Q2
$21.9M Buy
180,609
+754
+0.4% +$94.1K 3.24% 10
2018
Q1
$23M Sell
179,855
-675
-0.4% -$91.2K 3.58% 6
2017
Q4
$25.2M Buy
180,530
+449
+0.2% +$62.5K 3.95% 4
2017
Q3
$23.4M Buy
180,081
+745
+0.4% +$98.8K 3.89% 4
2017
Q2
$23.7M Sell
179,336
-400
-0.2% -$51K 4.07% 3
2017
Q1
$22.4M Sell
179,736
-825
-0.5% -$98.6K 3.86% 3
2016
Q4
$20.8M Buy
180,561
+775
+0.4% +$89.5K 3.77% 4
2016
Q3
$21.2M Sell
179,786
-1,050
-0.6% -$127K 3.89% 3
2016
Q2
$21.9M Sell
180,836
-558
-0.3% -$63.4K 4.06% 3
2016
Q1
$19.6M Buy
181,394
+163,237
+899% +$16.9M 3.64% 4
2015
Q4
$18.7K Sell
18,157
-162,872
-90% -$16.4M 3.5% 5
2015
Q3
$16.9M Sell
181,029
-100
-0.1% -$9.67K 3.34% 5
2015
Q2
$17.7M Sell
181,129
-351
-0.2% -$35.1K 3.34% 4
2015
Q1
$18.3M Buy
181,480
+1,285
+0.7% +$131K 3.42% 5
2014
Q4
$18.8M Buy
180,195
+850
+0.5% +$89.6K 3.57% 4
2014
Q3
$19.1M Sell
179,345
-6,272
-3% -$651K 3.85% 4
2014
Q2
$19.4M Buy
185,617
+150
+0.1% +$15.2K 3.89% 4
2014
Q1
$18.2M Buy
185,467
+1,400
+0.8% +$130K 3.8% 4
2013
Q4
$16.9M Sell
184,067
-1,300
-0.7% -$120K 3.57% 6
2013
Q3
$16.1M Sell
185,367
-300
-0.2% -$26.9K 3.68% 3
2013
Q2
$15.9M Buy
+185,667
New +$15.8M 3.87% 4

Other funds holding JNJ

Mogy Joel R Investment Counsel's JNJ Position: Q2 2026 in Review

Mogy Joel R Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 0.65% in Q2 2026, selling an estimated $46.6K and leaving 30,730 shares worth $7.8M. The position accounts for 0.45% of the portfolio, ranked #32.

Mogy Joel R Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.3M in Q2 2022. 3,169 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Mogy Joel R Investment Counsel held 30,730 shares of Johnson & Johnson worth $7.8M as of Q2 2026.
  • Mogy Joel R Investment Counsel sold 200 Johnson & Johnson shares in Q2 2026, an estimated $46.6K.
  • Johnson & Johnson made up 0.45% of Mogy Joel R Investment Counsel's portfolio in Q2 2026, its #32 holding.
  • Mogy Joel R Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Mogy Joel R Investment Counsel's Johnson & Johnson position peaked at $29.3M in Q2 2022.
  • 3,169 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Mogy Joel R Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.